S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

INDP Indaptus Therapeutics Inc

0.7956

-0.0063 (-0.79%)

08 Feb 2025 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics Inc News

Form S-3 - Registration statement under Securities Act of 1933
Thursday 6 February 2025 (3 days ago) • Edgar (US Regulatory)

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
Thursday 6 February 2025 (3 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 1 February 2025 (1 week ago) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Thursday 23 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 15 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Tuesday 14 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
Thursday 9 January 2025 (1 month ago) • GlobeNewswire Inc.

Form S-1 - General form for registration of securities under the Securities Act of 1933
Tuesday 24 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 23 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 23 November 2024 (3 months ago) • Edgar (US Regulatory)

Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
Saturday 23 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

More Indaptus Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions